These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 30882151)
1. Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial. Culverhouse RC; Chen LS; Saccone NL; Ma Y; Piper ME; Baker TB; Bierut LJ Nicotine Tob Res; 2020 Feb; 22(2):248-255. PubMed ID: 30882151 [TBL] [Abstract][Full Text] [Related]
2. Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. Chen LS; Baker TB; Piper ME; Breslau N; Cannon DS; Doheny KF; Gogarten SM; Johnson EO; Saccone NL; Wang JC; Weiss RB; Goate AM; Bierut LJ Am J Psychiatry; 2012 Jul; 169(7):735-42. PubMed ID: 22648373 [TBL] [Abstract][Full Text] [Related]
3. Role of CHRNA5-A3 genetic Locus variants and developing drug for chronic obstructive pulmonary disease. Lococo F; Cesario A; Petracca-Ciavarella L; Granone P; Russo P Curr Med Chem; 2012; 19(34):5863-70. PubMed ID: 23061658 [TBL] [Abstract][Full Text] [Related]
4. Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy. Sarginson JE; Killen JD; Lazzeroni LC; Fortmann SP; Ryan HS; Schatzberg AF; Murphy GM Am J Med Genet B Neuropsychiatr Genet; 2011 Apr; 156B(3):275-84. PubMed ID: 21268243 [TBL] [Abstract][Full Text] [Related]
5. The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations. Barrie ES; Hartmann K; Lee SH; Frater JT; Seweryn M; Wang D; Sadee W Hum Mutat; 2017 Jan; 38(1):112-119. PubMed ID: 27758088 [TBL] [Abstract][Full Text] [Related]
6. Combined genetic influence of the nicotinic receptor gene cluster CHRNA5/A3/B4 on nicotine dependence. Lee SH; Ahn WY; Seweryn M; Sadee W BMC Genomics; 2018 Nov; 19(1):826. PubMed ID: 30453884 [TBL] [Abstract][Full Text] [Related]
7. Variation in the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 and its interaction with recent tobacco use influence cognitive flexibility. Zhang H; Kranzler HR; Poling J; Gelernter J Neuropsychopharmacology; 2010 Oct; 35(11):2211-24. PubMed ID: 20631687 [TBL] [Abstract][Full Text] [Related]
8. Associations of variants in CHRNA5/A3/B4 gene cluster with smoking behaviors in a Korean population. Li MD; Yoon D; Lee JY; Han BG; Niu T; Payne TJ; Ma JZ; Park T PLoS One; 2010 Aug; 5(8):e12183. PubMed ID: 20808433 [TBL] [Abstract][Full Text] [Related]
9. Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers. Halldén S; Sjögren M; Hedblad B; Engström G; Hamrefors V; Manjer J; Melander O J Intern Med; 2016 Apr; 279(4):388-98. PubMed ID: 26689306 [TBL] [Abstract][Full Text] [Related]
10. Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance. Winterer G; Mittelstrass K; Giegling I; Lamina C; Fehr C; Brenner H; Breitling LP; Nitz B; Raum E; Müller H; Gallinat J; Gal A; Heim K; Prokisch H; Meitinger T; Hartmann AM; Möller HJ; Gieger C; Wichmann HE; Illig T; Dahmen N; Rujescu D Am J Med Genet B Neuropsychiatr Genet; 2010 Dec; 153B(8):1448-58. PubMed ID: 20886544 [TBL] [Abstract][Full Text] [Related]
11. Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial. Chen LS; Baker TB; Miller JP; Bray M; Smock N; Chen J; Stoneking F; Culverhouse RC; Saccone NL; Amos CI; Carney RM; Jorenby DE; Bierut LJ Clin Pharmacol Ther; 2020 Dec; 108(6):1315-1325. PubMed ID: 32602170 [TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of Chr15q25 nicotinic gene cluster and the relationship between smoking, cognition and ADHD. Schuch JB; Polina ER; Rovaris DL; Kappel DB; Mota NR; Cupertino RB; Silva KL; Guimarães-da-Silva PO; Karam RG; Salgado CAI; White MJ; Rohde LA; Grevet EH; Bau CHD J Psychiatr Res; 2016 Sep; 80():73-78. PubMed ID: 27302872 [TBL] [Abstract][Full Text] [Related]
14. Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism. Wen L; Jiang K; Yuan W; Cui W; Li MD Mol Neurobiol; 2016 Jan; 53(1):472-484. PubMed ID: 25471942 [TBL] [Abstract][Full Text] [Related]
15. Variants located upstream of CHRNB4 on chromosome 15q25.1 are associated with age at onset of daily smoking and habitual smoking. Kapoor M; Wang JC; Bertelsen S; Bucholz K; Budde JP; Hinrichs A; Agrawal A; Brooks A; Chorlian D; Dick D; Hesselbrock V; Foroud T; Kramer J; Kuperman S; Manz N; Nurnberger J; Porjesz B; Rice J; Tischfield J; Xuei X; Schuckit M; Edenberg HJ; Bierut LJ; Goate AM PLoS One; 2012; 7(3):e33513. PubMed ID: 22438940 [TBL] [Abstract][Full Text] [Related]
16. Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans. Li MD; Xu Q; Lou XY; Payne TJ; Niu T; Ma JZ Am J Med Genet B Neuropsychiatr Genet; 2010 Apr; 153B(3):745-56. PubMed ID: 19859904 [TBL] [Abstract][Full Text] [Related]
17. Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women. Tomaz PRX; Santos JR; Scholz J; Abe TO; Gaya PV; Negrão AB; Krieger JE; Pereira AC; Santos PCJL BMC Med Genet; 2018 Apr; 19(1):55. PubMed ID: 29621993 [TBL] [Abstract][Full Text] [Related]
18. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking. Tyndale RF; Zhu AZ; George TP; Cinciripini P; Hawk LW; Schnoll RA; Swan GE; Benowitz NL; Heitjan DF; Lerman C; PLoS One; 2015; 10(5):e0128109. PubMed ID: 26010901 [TBL] [Abstract][Full Text] [Related]
19. Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide. Bloom AJ; Hartz SM; Baker TB; Chen LS; Piper ME; Fox L; Martinez M; Hatsukami D; Johnson EO; Laurie CC; Saccone NL; Goate A; Bierut LJ Ann Am Thorac Soc; 2014 Sep; 11(7):1003-10. PubMed ID: 25072098 [TBL] [Abstract][Full Text] [Related]
20. Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation. Chen LS; Baker TB; Jorenby D; Piper M; Saccone N; Johnson E; Breslau N; Hatsukami D; Carney RM; Bierut LJ Drug Alcohol Depend; 2015 Sep; 154():278-82. PubMed ID: 26142345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]